An Oncology biotech pioneering  RAD51 inhibition to treat high replication stress tumors

Satya’s MedChem leadership expanded

Navnath Karche, PhD, a Medicinal Chemist with over 18 years of experience across multiple discovery programs in Oncology, Metabolic Disorders, and CNS therapeutic areas. Navnath previously worked at Dai-Ichi and Lupin, after his PhD from Pune University and post-doc from Rouen, France.

Ganesh Gudade, with over 20 years of MedChem experience at Lupin, Glenmark and Wockhardt, has also joined the team as Associate Director, Medicinal Chemistry
Scroll to Top